Crinetics Pharmaceuticals (CRNX) Stock Price

$37.46 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    6

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Crinetics Pharmaceuticals, AI stock picks, stock alerts and much more.

Sign up

CRNX AI Stock Analysis

AI stock analysis for CRNX is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Crinetics Pharmaceuticals (CRNX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Crinetics Pharmaceuticals (CRNX) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Crinetics Pharmaceuticals (CRNX), currently trading at $37.46, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About CRNX

LSE

  • Crinetics Pharmaceuticals, Inc.

  • Symbol

    CRNX

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    3.5B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
INO Inovio Pharmaceuticals
INO		 $2.24
0.9%
2
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6

News

Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences

Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences
February 20, 2025. globenewswire.com
Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness

Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness
January 2, 2025. seekingalpha.com
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
November 14, 2024. globenewswire.com
Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript

Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript
November 12, 2024. seekingalpha.com

CRNX Alternative Data

Web Traffic

Crinetics Pharmaceuticals receives an estimated 15488 monthly visitors to crinetics.com.

  • Web Traffic

    15488

  • Change from Previous Month

    4.8%

  • 3 Month Change

    2.3%

  • YoY Change

    2.3%

News Mentions

Crinetics Pharmaceuticals was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

Crinetics Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Twitter Followers

Crinetics Pharmaceuticals has 945 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.

  • Twitter Followers

    945

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    1.3%

  • YoY Change

    1.3%

Facebook Engagement

Crinetics Pharmaceuticals has engaged 4 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    4

  • Daily Change

    300%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Instagram Followers

Crinetics Pharmaceuticals has 141 Instagram Followers on its main Instagram account, up by 0.7% over the last month.

  • Instagram Followers

    141

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    3.7%

  • YoY Change

    3.7%

LinkedIn Followers

25,792 are following Crinetics Pharmaceuticals on LinkedIn, up by 11.7% over the last month.

  • LinkedIn Followers

    25792

  • Daily Change

    0.7%

  • 1 Month Change

    11.7%

  • 3 Month Change

    28.4%

Job Postings

Crinetics Pharmaceuticals currenly has an estimated 62 open job postings, up by 12.7% over the last month.

  • Job Postings

    62

  • Daily Change

    6.9%

  • 1 Month Change

    12.7%

  • 3 Month Change

    44.2%

  • YoY Change

    44.2%

LinkedIn Employees

According to LinkedIn, Crinetics Pharmaceuticals has 390 employees, up by 3.2% over the last month.

  • LinkedIn Employees

    390

  • Daily Change

    0%

  • 1 Month Change

    3.2%

  • 3 Month Change

    8.9%

  • YoY Change

    8.9%

Business Outlook

  • Business Outlook

    85

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

CRNX Financials

CRNX Key Metrics

  • Total Revenue

    $0

  • Net Income

    -$76.8M

  • Earnings per Share

    -$0.96

  • Free cash flow

    -$63.4M

  • EBITDA

    -$87M

  • EBITDA Ratio

    0

  • Total Assets

    $937.4M

CRNX 2-year Revenue & Income
CRNX 2-year Free Cash Flow

CRNX Technicals

CRNX SMA
CRNX RSI

FAQ

What's the current price of Crinetics Pharmaceuticals (CRNX) Stock?
The price of an Crinetics Pharmaceuticals (CRNX) share is $37.46.

What's the market cap of Crinetics Pharmaceuticals?
The current market cap of Crinetics Pharmaceuticals is 3.5B.

Should I buy or sell CRNX?
Crinetics Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Crinetics Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.

Is Crinetics Pharmaceuticals a good investment?
The current analysis of Crinetics Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Crinetics Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Crinetics Pharmaceuticals (CRNX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Crinetics Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Crinetics Pharmaceuticals (CRNX) that investors often compare it to?
Crinetics Pharmaceuticals (CRNX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Crinetics Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Crinetics Pharmaceuticals' stock price to be around $38.27 in 2026. Starting from the current price of $37.46, this represents a 2.2% change in price, indicating a neutral outlook for the stock.

How to buy Crinetics Pharmaceuticals (CRNX) Stock?
Crinetics Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Crinetics Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.